The Biden administration is embracing healthcare efforts designed to reduce the deadly impact of fentanyl addiction — but many state legislatures are resisting the "harm reduction" approach. But first ...

If people want to use drugs, they’re going to. And if they’re going to use drugs, they should have access to clean supplies to prevent the spread of hepatitis C and HIV, and naloxone to prevent ...

When people are supported in pursuing their own goals, "success" can take many different forms, as these examples illustrate.

San Francisco, Philadelphia and others are retreating from “harm reduction” strategies that have helped reduce deaths but which critics, including Trump, say have contributed to pervasive public drug ...

Harm reduction is an approach to treating those with alcohol and other substance-use problems that does not require patients to commit to complete abstinence before treatment begins. Instead, an array ...

Harm reduction was adopted by public institutions to help stem the spread of HIV/AIDS in the 1980s. But it originated in self-advocacy by drug users, sex workers, and trans activists. Harm reduction, ...

Since 2021, harm-reduction organizations have distributed hundreds of thousands of sterile needles and syringes to drug users ...

PORTLAND, Ore. — In some major cities across the United States, recent reporting from The New York Times finds that there's now a turn away from once-favored harm reduction efforts meant to blunt the ...

Ms. Szalavitz is a contributing Opinion writer who covers addiction and public policy. See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de búsqueda.

But first, we turn to the fentanyl epidemic. Yesterday Pennsylvania state Senate passed a bill that would ban supervised drug injection clinics. These are programs that aim to reduce overdose rates.

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. But first, we turn to the fentanyl ...